DJ Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ rose 4.35% to $1.20 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 1.33% to 26,289.71 and Dow Jones Industrial Average falling 0.22% to 53,343.40.
This was the stock's seventh consecutive day of gains.
Inovio Pharmaceuticals Inc. closed 59.72% short of its 52-week high of $2.98, which the company achieved on September 9th.
The stock outperformed some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ rose 3.33% to $271.11, Statera Biopharma Inc. (STAB) fell 50.00% to $0.00, and Pfizer Inc. $(PFE)$ rose 1.41% to $27.25.
Trading volume (4.7 M) eclipsed its 50-day average volume of 3.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 18, 2026.